Chief Physician, Master's Supervisor. Specializes in conventional and minimally‑invasive coronary artery bypass grafting (especially total‑arterial revascularization using bilateral in‑situ internal mammary arteries), valve surgery, great‑vessel surgery, and correction of hypertrophic obstructive cardiomyopathy and Ebstein's anomaly, among other common cardiac procedures. Has presided over and participated in research projects including Clinical Efficacy Evaluation of Branched Aortic Stents (Shanghai Science and Technology Commission, Grant No.: 17DZ1930204), Clinical Study on the Trans‑thoracic Interventional Prosthetic Heart Valve System Access (Shanghai Science and Technology Commission, Grant No.: 15DZ1942302), and Establishment and Clinical Evaluation of Animal Models for Trans‑apical Minimally‑Invasive Aortic Valve Implantation (Shanghai Science and Technology Commission, Grant No.: 14DZ1940903). 4 papers as first author / co‑first author and 7 papers as corresponding author (10 SCI papers, 1 core‑journal paper). Received the Finalist Award for the 2016 Zhongshan Hospital Clinical New Technology Application and Promotion Award (Skeletonized Bilateral In‑situ Internal Mammary Artery‑Coronary Artery Bypass Grafting Assisted by Real‑Time Blood Flow Measurement), the Second‑Class Shanghai Science and Technology Award of 2020 (Technical Optimization, Promotion and Application of Minimally‑Invasive Surgical Treatment for Heart Valve Disease), and the Third‑Class Huaxia Medical Science and Technology Award of 2020 (Technical Optimization, Promotion and Application of Minimally‑Invasive Surgical Treatment for Heart Valve Disease).